| 내 용 |
Are you a student? <a href=" http://rumahminimalisku.web.id/2018/02/02/rumah-mewah-minimalis/ ">generic acyclovir cream 5</a> Turnover from Glivec/Gleevec (imatinib), for chronic myeloid leukaemia and gastrointestinal stromal tumours was down 3% at $1.13 billion, while the successor to Glivec, Tasigna (nilotinib), also approved for CML, contributed $315 million, up 21%.
|
